| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |